Drugs / Buzhong Yiqi plus and minus formula
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04664010 | Feb 2020 → Sep 2022 | COVID-19 | Xi'an International Medical Center Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Buzhong Yiqi plus and minus formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04664010 ↗ |
| Route | Oral | “Suggested usage: 1 dose once, twice a day, taking with warm water” NCT04664010 ↗ |